Ausgabe 4/2008
Inhalt (13 Artikel)
Cytotoxic effects of curcumin on osteosarcoma cell lines
Denise K. Walters, Roman Muff, Bettina Langsam, Walter Born, Bruno Fuchs
Identification of small molecules inducing apoptosis by cell-based assay using fission yeast deletion mutants
Kyung-Sook Chung, Nam-Hui Yim, Seung-Hee Lee, Shin-Jung Choi, Kyung-Sun Hur, Kwang-Lae Hoe, Dong-Uk Kim, Sondra Goehle, Hyung-Bae Kim, Kyung-Bin Song, Hyang-Sook Yoo, Ki-Hwan Bae, Julian Simon, Misun Won
The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells
Vesna Vučić, Ana Nićiforović, Miroslav Adžić, Marija B. Radojčić, Sabera Ruždijić
Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine
Ashish Aggarwal, Anna Kruczynski, Anthony Frankfurter, John J. Correia, Sharon Lobert
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia
Wendy Stock, Samir D. Undevia, Carol Bivins, Farhad Ravandi, Olatoyosi Odenike, Stefan Faderl, Elizabeth Rich, Gautam Borthakur, Lucy Godley, Srdan Verstovsek, Andrew Artz, William Wierda, Richard A. Larson, Yanming Zhang, Jorge Cortes, Mark J. Ratain, Francis J. Giles
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer
Daniel G. Stover, A. Craig Lockhart, Jordan D. Berlin, Emily Chan, Alan B. Sandler, Jeffery A. Sosman, Victoria Middlebrook, Steven Nicol, Mace L. Rothenberg
Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies
Priscila H. Goncalves, Francine High, Paul Juniewicz, Gareth Shackleton, Jing Li, Scott Boerner, Patricia M. LoRusso
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
Sharon L. Sanborn, Matthew M. Cooney, Afshin Dowlati, Joanna M. Brell, Smitha Krishnamurthi, Joseph Gibbons, Joseph A. Bokar, Charles Nock, Anne Ness, Scot C. Remick
Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer
Faruk Tas, Nese Guney, Duygu Derin, Hakan Camlica, Adnan Aydiner, Erkan Topuz
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
Steven Attia, Jill Kolesar, Michelle R. Mahoney, Henry C. Pitot, Daniel Laheru, James Heun, Wei Huang, Jens Eickhoff, Charles Erlichman, Kyle D. Holen
A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma
Allen L. Cohn, J. William Myers, Steven Mamus, Charles Deur, Steven Nicol, Karen Hood, Muhammad M. Khan, Des Ilegbodu, Lina Asmar
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma
Byeong-Bae Park, Young-Hyuck Im, In Gyu Hwang, Sang Cheol Lee, Jin Seok Ahn, Myung-Ju Ahn, Ho-Yeong Lim, Won Ki Kang, Keunchil Park
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation
J. Tol, A. Cats, L. Mol, M. Koopman, M. M. E. M. Bos, J. J. M. van der Hoeven, N. F. Antonini, J. H. J. M. van Krieken, C. J. A. Punt